- Epidemiology, management, and prevention of cholera
-
Bae IG
- KMID: 2368924
- J Korean Med Assoc.
- 2017 Feb;60(2):140-146.
- doi: 10.5124/jkma.2017.60.2.140
Cholera is an acute secretory form of diarrhea caused by a potent enterotoxin (cholera toxin) after ingestion of toxigenic Vibrio cholerae of the O1 or O139 serogroups. Although cholera is... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
-
Lee EY, Lee S, Rho S, Kim JO, Choi SK, Lee YJ, Park JY, Song M, Yang JS
- KMID: 2418088
- Clin Exp Vaccine Res.
- 2018 Jul;7(2):104-110.
- doi: 10.7774/cevr.2018.7.2.104
PURPOSE: An oral cholera vaccine (OCV), Euvichol, with thimerosal (TM) as preservative, was prequalified by the World Health Organization (WHO) in 2015. In recent years, public health services and regulatory... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
-
Baik YO, Choi SK, Kim JW, Yang JS, Kim IY, Kim CW, Hong JH
- KMID: 1774453
- J Korean Med Sci.
- 2014 Apr;29(4):494-501.
- doi: 10.3346/jkms.2014.29.4.494
The safety, tolerability and immunogenicity of an oral cholera vaccine (OCV) was assessed in adult Korean male through an open-label, non-comparative clinical study. Two doses of vaccine with an interval... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Some Drugs and Toxins on Positive Rate of Y-Body in Leukocytes of Rabbits
-
Yun NS, Lee HY
- KMID: 2060007
- Korean J Urol.
- 1976 Jun;17(2):77-94.
This study was carried out to investigate the response of interphase Y chromosome to some drugs and toxins by observing the rate of leukocytes showing Y-body in the peripheral blood.... -
- CITED
-
- Close
- SHARE
-
- Close
